A Study of TAVO101 in Atopic Dermatitis Patients
NCT06176040
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
TAVO101
Sponsor
Tavotek Biotherapeutics